116 related articles for article (PubMed ID: 38855327)
21. Whole-body hyperthermia combined with chemotherapy and intensity-modulated radiotherapy for treatment of advanced nasopharyngeal carcinoma: a retrospective study with propensity score matching.
Zheng N; Xu A; Lin X; Mo Z; Xie X; Huang Z; Liang Y; Cai Z; Tan J; Shao X
Int J Hyperthermia; 2021; 38(1):1304-1312. PubMed ID: 34468276
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of induction chemotherapy in lymph node-positive stage III nasopharyngeal carcinoma and identification of beneficiaries based on clinical features: A propensity score matching analysis.
Xu YC; Chen KH; Liang Y; Chen KQ; Liang ZG; Zeng FY; Li L; Qu S; Zhu XD
Oral Oncol; 2023 Nov; 146():106554. PubMed ID: 37633201
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Concurrent Chemoradiotherapy Combined With Induction Chemotherapy or Adjuvant Chemotherapy in Patients With Stage II-IVA Nasopharyngeal Carcinoma: A Propensity Score Matching Analysis and Meta-Analysis.
Yang J; Liang ZG; Jiang YT; Chen KH; Li L; Qu S; Zhu XD
Front Oncol; 2021; 11():778836. PubMed ID: 34926289
[TBL] [Abstract][Full Text] [Related]
24. Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.
Rudra S; Hui C; Rao YJ; Samson P; Lin AJ; Chang X; Tsien C; Fergus S; Mullen D; Yang D; Thotala D; Hallahan D; Campian JL; Huang J
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):217-225. PubMed ID: 29502931
[TBL] [Abstract][Full Text] [Related]
25. Concurrent chemoradiotherapy combined with nimotuzumab in stage III-IVa nasopharyngeal carcinoma: a retrospective analysis.
Cai Z; Chen D; Qiu W; Liang C; Huang Y; Zhou J; Zhan Z; Xiang Y; Guo X; Lv X
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2327-2344. PubMed ID: 36289067
[TBL] [Abstract][Full Text] [Related]
26. Advanced-Stage Nasopharyngeal Carcinoma: Restaging System after Neoadjuvant Chemotherapy on the Basis of MR Imaging Determines Survival.
Liu LT; Chen QY; Tang LQ; Zhang L; Guo SS; Xie CM; Liu XW; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
Radiology; 2017 Jan; 282(1):171-181. PubMed ID: 27479804
[TBL] [Abstract][Full Text] [Related]
27. High proportion of circulating CD8 + CD28- senescent T cells is an independent predictor of distant metastasis in nasopharyngeal canrcinoma after radiotherapy.
Xu X; Wei F; Xiao L; Wu R; Wei B; Huang S; Yi J; Cui W
J Transl Med; 2023 Jan; 21(1):64. PubMed ID: 36721233
[TBL] [Abstract][Full Text] [Related]
28. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
[TBL] [Abstract][Full Text] [Related]
29. Docetaxel and cisplatin induction chemotherapy with or without fluorouracil in locoregionally advanced nasopharyngeal carcinoma: A retrospective propensity score matching analysis.
Tao HY; Zhan ZJ; Qiu WZ; Liao K; Yuan YW; Zheng RH
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e111-e118. PubMed ID: 33945215
[TBL] [Abstract][Full Text] [Related]
30. Preoperative Metabolic Syndrome and HDL-C Level Predict the Prognosis of Patients Following Radical Cystectomy: A Propensity Score Matching Study.
Liu Z; Bi H; He W; Zhu X; He J; Lu M; Lu J
Front Oncol; 2022; 12():833305. PubMed ID: 35463353
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of the Albumin-to-Alkaline Phosphatase Ratio before Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma.
Yang L; Gao J; Zhou Y; Tao Z; He J; Yang J; Wang R; Zhang Y; Huang Y; Zhou L; Sun B
Chemotherapy; 2021; 66(1-2):40-46. PubMed ID: 33601377
[TBL] [Abstract][Full Text] [Related]
32. The effect of primary tumor volume on the prognosis of nasopharyngeal carcinoma in era of volumetric modulated arc therapy: a propensity score matched cohort study.
Lin X; Wang B; Zheng F; Fei Z; Chen C
Braz J Otorhinolaryngol; 2023; 89(3):374-382. PubMed ID: 37105031
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Chemotherapy in Survival of Stage I Nasopharyngeal Carcinoma.
Ma JL; Huang ST; Jiang YM; Pan XB
Front Oncol; 2021; 11():735817. PubMed ID: 34722284
[TBL] [Abstract][Full Text] [Related]
34. The impairment of induction chemotherapy for stage II nasopharyngeal carcinoma treated with intensity-modulated radiotherapy with or without concurrent chemotherapy: A propensity score-matched analysis.
Lai Y; Wang C; Yang X; He S; Wang Y; Chen Y
Cancer Med; 2023 Feb; 12(3):2970-2978. PubMed ID: 36114787
[TBL] [Abstract][Full Text] [Related]
35. Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Hepatocellular Carcinoma Treated with Conventional Transcatheter Arterial Chemoembolization: A Propensity Score Matched Analysis.
Deng Z; Zhang W; Peng J; Gao L; Zhang C; Lei K; Gong J; Xiong B
Cardiovasc Intervent Radiol; 2024 May; 47(5):592-603. PubMed ID: 38605220
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
Su L; Zhang M; Zhang W; Cai C; Hong J
Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
[TBL] [Abstract][Full Text] [Related]
37. A Novel Prognostic Score Including the CD4/CD8 for AIDS-Related Lymphoma.
Chen J; Liu X; Qin S; Ruan G; Lu A; Zhang J; Wu Y; Xie Z; Peng J
Front Cell Infect Microbiol; 2022; 12():919446. PubMed ID: 35873145
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of chemotherapy in addition to concurrent chemoradiotherapy in T3-4N0-1 nasopharyngeal carcinoma: a propensity score matching study.
Wu LR; Yu HL; Jiang N; Jiang XS; Zong D; Wen J; Huang L; Xie P; Chen W; Wang TT; Gu DY; Yan PW; Yin L; He X
Oncotarget; 2017 Sep; 8(44):76807-76815. PubMed ID: 29100350
[TBL] [Abstract][Full Text] [Related]
39. Predictive and Prognostic Role of Peripheral Blood T-Cell Subsets in Triple-Negative Breast Cancer.
Li M; Xu J; Jiang C; Zhang J; Sun T
Front Oncol; 2022; 12():842705. PubMed ID: 35242718
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Value of Circulating Lipoprotein in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
Yao JJ; He XJ; Lawrence WR; Zhang WJ; Kou J; Zhang F; Zhou GQ; Wang SY; Sun Y
Cell Physiol Biochem; 2018; 48(1):285-292. PubMed ID: 30011397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]